Gut Bacteria Chemical Linked to Alzheimer's Risk
University of Wisconsin researchers find gut bacteria produce a compound, ImP, that may raise Alzheimer's risk in a study of nearly 1,200 participants.
A compound produced by gut bacteria may increase the risk of developing Alzheimer's disease, according to new research from the University of Wisconsin. The study, led by Barbara Bendlin, PhD, and Federico Rey, PhD, examined blood levels of imidazole propionate (ImP) — a chemical generated in the digestive tract — in nearly 1,200 participants enrolled in the Wisconsin Alzheimer's Disease Research Centre. The findings add significant weight to the growing body of evidence linking gut health to brain health.
Why This Matters for the Gut-Brain Connection
The gut-brain connection — the bidirectional communication network between the digestive system and the brain — has become one of the most active areas of microbiome research worldwide. In the UK, institutions such as King's College London and the University of Reading have been at the forefront of investigating how the microbiome influences neurological health. The British Gut Project has also highlighted how the diversity of gut bacteria varies considerably across the UK population, with diet, age, and lifestyle all playing significant roles. Research linking specific microbial metabolites to neurodegenerative disease marks a meaningful step forward in this field.
What the Study Found
According to the researchers, imidazole propionate (ImP) was identified as a compound that may elevate Alzheimer's disease risk, based on its measured blood concentrations in study participants. The study involved close to 1,200 volunteers connected to the Wisconsin Alzheimer's Disease Research Centre, making it a substantial dataset for this line of enquiry. The scientists report that ImP is produced during the bacterial metabolism of the amino acid histidine in the gut. Per the source, the research suggests that the chemical's presence in the bloodstream may serve as a measurable indicator of neurological risk linked to gut microbial activity.
What This Means for UK Readers Interested in Gut Health
For health-conscious adults in the UK, these findings reinforce why improving gut health naturally — through dietary choices aligned with the NHS Eatwell Guide, including high-fibre foods, fermented products, and reduced ultra-processed food intake — may have implications that extend well beyond digestion. The NHS has increasingly acknowledged the gut-brain axis as clinically relevant, and UK microbiome research continues to expand understanding of how microbial metabolites travel from the gut to influence systemic and neurological health.
This research underscores the importance of the gut-brain connection as a legitimate focus for preventive health strategies. While the study does not establish that ImP directly causes Alzheimer's disease, the University of Wisconsin team's findings suggest that gut bacteria and the chemicals they produce warrant serious attention from neuroscientists and dietitians alike — including those working within UK health and research institutions. As microbiome science matures, markers such as ImP could one day inform risk assessment tools available through NHS pathways.
You might also like
- How to Improve Gut Health with Meditation
- Xylitol Chewing Gum: Good for Teeth and Gut Health
- 7 Gut Health Mistakes Harming Your Microbiome
96 Bacterial Strains. Two Shots a Day.
GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?